QNCX icon

Quince Therapeutics
QNCX

Overview Fund Activity

45 hedge funds and large institutions have $12M invested in Quince Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 8 closing their positions.

Holders
45
Holders Change
-5
Holders Change %
-10%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
14
Closed
8
Calls
$360K
Puts
$6K
Net Calls
+$354K
Net Calls Change
+$198K

Top Buyers

1
TCM
1
Tang Capital Management
California
$5.65M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$358K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.39M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$196K
5
Bank of America
5
Bank of America
North Carolina
$23.8K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$387K
2
Two Sigma Investments
2
Two Sigma Investments
New York
$198K
3
Federated Hermes
3
Federated Hermes
Pennsylvania
$1.25K
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$73K
5
ECG
5
EPIQ Capital Group
California
$1.5M
Name Market Value Shares Shares
Change 		Shares
Change %
Wolverine Trading
51
Wolverine Trading
Illinois
– – – –
Belvedere Trading
52
Belvedere Trading
Illinois
– – – –
HGERS
53
Householder Group Estate & Retirement Specialist
Arizona
$0 100 – –
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
TRCT
55
Tower Research Capital (TRC)
New York
$0 98 +98 New
Barclays
56
Barclays
United Kingdom
$0 100 +100 New
1 2
3